Evaluate Clinical Benefit of Local Treatment With KD Intra-Articular® Gel in Patients With Osteoarthritis (NO-DOLOR2)

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

March 17, 2022

Primary Completion Date

September 1, 2022

Study Completion Date

December 14, 2023

Conditions
Osteoarthritis, HipOsteoarthritis ThumbOsteoarthritis Ankle
Interventions
DEVICE

KD Intra-Articular® gel

Depending on the joint, 3 injections will be administrated to the patient: KD Intra-Articular® gel 2.2% - 44 mg in 2 ml - (Pronolis® HD one 2.2%) in the case of shoulder and hip, or KD Intra-Articular® gel 1.6% - 16 mg in 1 ml - (Pronolis® HD mini 1.6%) in the case of the ankle and base of the thumb. The administration of the infiltrations will be with an interval of one week.

Trial Locations (1)

08003

Hospital Del Mar, Barcelona

All Listed Sponsors
lead

Procare Health Iberia S.L.

INDUSTRY